🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study consists of 3 periods: A Screening Period (up to 45 days), a doub...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-12-17
Trial ID
NCT06833931
Treatments Being Tested
The main purpose of this study is to investigate whether dupilumab is effec...
Status
Completed
Location
Regeneron study Site
Start Date
2020-10-28
Trial ID
NCT04206553
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of differe...
Status
Recruiting
Location
Inmagene Site 1
Start Date
2025-06-17
Trial ID
NCT07037901
The primary purpose of the study is to determine the safety and tolerabilit...
Status
Completed
Location
Research Site
Start Date
2009-12
Trial ID
NCT01039701
The objective of this study is to assess the feasibility of a novel colonic...
Status
Completed
Location
McMaster Children's Hospital
Start Date
2018-12-01
Trial ID
NCT03378167
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of Incobot...
Status
Withdrawn
Location
Beth Israel Deaconess Medical Center
Start Date
2012-03
Trial ID
NCT01565395
Treatments Being Tested
There is growing evidence that thyroid axis dysfunction may contribute to t...
Status
Completed
Location
University of California in Los Angeles
Start Date
2004-03
Trial ID
NCT01528839
Treatments Being Tested
This is a phase 2, single-center prospective, double-blind, placebo-control...
Status
Terminated
Location
Stanford University
Start Date
2021-04-06
Trial ID
NCT04839575
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of leronlima...
Status
Completed
Location
Arthritis & Rheumatic Disease Specialties
Start Date
2021-03-01
Trial ID
NCT04678830
Treatments Being Tested
Sjogren's syndrome (SS) is a chronic, multisystem autoimmune disease charac...
Status
Withdrawn
Location
Universitair Medisch Centrum Utrecht /ID# 214029
Start Date
2020-03-06
Trial ID
NCT05217472
Treatments Being Tested